Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Wenzhou Medical UniversityActive in the last 2 years

Haotian Fu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2437-1917; OpenAlex author ID A5151703651. Sources: OpenAlex.

Their work

Papers
3 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. The Moonlighting Function of Glutaminase 2 Promotes Immune Evasion of Pancreatic Ductal Adenocarcinoma by Tubulin Tyrosine Ligase-like 1-Mediated Yes1 Associat… First author DOI 10.1053/j.gastro.2025.01.240↗
  2. Study of the Mechanism by Which Curcumin Cooperates with Sestrin2 to Inhibit the Growth of Pancreatic Cancer. Co-author DOI 10.1155/2021/7362233↗
  3. Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer. First author DOI 10.18632/aging.203575↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yunfeng Shan · 2 shared papers, 2021 · strength 0.30
  2. Yuan Ding · 1 shared paper, 2025 · strength 0.22
  3. Xiao Chen · 1 shared paper, 2025 · strength 0.22
  4. Weilin Wang · 1 shared paper, 2025 · strength 0.22
  5. Ni Xie · 1 shared paper, 2021 · strength 0.16
  6. Xuhui Fan · 1 shared paper, 2021 · strength 0.16
  7. Hangcheng Guo · 1 shared paper, 2021 · strength 0.16
  8. Hongwei Sun · 1 shared paper, 2021 · strength 0.14
  9. Fubiao Ni · 1 shared paper, 2021 · strength 0.14
  10. Ding Li · 1 shared paper, 2021 · strength 0.14
  11. Shengjie Dai · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.